Bladder Cancer

Latest News

Phase 3 ENLIGHTED trial: Padeliporfin VTP shows promise in low-grade UTUC
Phase 3 ENLIGHTED trial: Padeliporfin VTP shows promise in low-grade UTUC

November 7th 2024

At the end of the induction phase, 86% of patients had achieved a complete response.

Study to assess performance of CxBladder test in urothelial carcinoma surveillance
Study to assess performance of CxBladder test in urothelial carcinoma surveillance

November 6th 2024

TYRA-300 shows encouraging safety, efficacy in FGFR3+ metastatic urothelial carcinoma
TYRA-300 shows encouraging safety, efficacy in FGFR3+ metastatic urothelial carcinoma

October 31st 2024

UGN-102 data published in Journal of Urology as FDA weighs NMIBC approval
UGN-102 data published in Journal of Urology as FDA weighs NMIBC approval

October 28th 2024

FDA grants 510(k) clearance to Ambu’s HD cystoscopy solution
FDA grants 510(k) clearance to Ambu’s HD cystoscopy solution

October 23rd 2024

© 2024 MJH Life Sciences

All rights reserved.